Introducing Twelve Converter! Real-time currency rates at your fingertips. Available on Android, iOS soon!

VRTX

444.1 USD
2.05
0.46%
Last update Jun 2, 3:50 PM EDT
Main market
Day range
440.525
447.4
Previous close
442.049988
Open
440.525
Access this stock data via API
Subscribe
Vertex Pharmaceuticals Inc.
444.10
2.05
0.46%

Overview

Description

Vertex Pharmaceuticals Inc. is a leading biotechnology company focused on the discovery, development, and commercialization of innovative therapies for serious diseases. Primarily, Vertex is known for its pioneering work in treating cystic fibrosis (CF), a genetic disorder that affects respiratory and digestive systems. Through its robust portfolio of CF-focused therapies, Vertex addresses a significant unmet medical need, improving the quality of life for patients worldwide. The company's research pipeline also includes promising treatments for other serious conditions, including sickle cell disease and beta thalassemia. Based in Boston, Massachusetts, Vertex Pharmaceuticals serves the global healthcare sector, collaborating with key industry players and academic institutions to advance its scientific initiatives. Its role in the biotechnology landscape is significant, both for its impact on patient outcomes and its contribution to advancing medical science through innovation and targeted therapeutic solutions.

About

CEO
Dr. Reshma Kewalramani FASN, M.D.
Employees
6100
Address
50 Northern Avenue
Boston, 02210, MA
United States
Phone
617 341 6100
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Biotechnology
Country
United States
MIC code
XNGS
Main market

Exchange is currently active.
Closing in 9 minutes

15:50
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).